Open AccessLRP6 as a biomarker of poor prognosis of breast cancer
Author(s) -
Yunke Zhang,
C. Shu,
Yusufu Maimaiti,
Shuntao Wang,
Chong Lu,
Jing Zhou
Publication year - 2021
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-21-194
Subject(s) - breast cancer , medicine , lrp6 , oncology , cancer , biomarker , proportional hazards model , cancer research , survival analysis , wnt signaling pathway , metastasis , pathology , biology , gene , biochemistry
Recently, low-density lipoprotein receptor (LDLR)-related protein 6 (LRP6) has been the focus of molecular targeted therapy for breast cancer; however, its role in breast cancer is still controversial. The purpose of this study was to investigate the effect of LRP6 overexpression on the prognosis of breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom